Literature DB >> 15466861

Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway.

Sanjeev Puri1, Brenda S Magenheimer, Robin L Maser, Erin M Ryan, Christopher A Zien, Danielle D Walker, Darren P Wallace, Scott J Hempson, James P Calvet.   

Abstract

Regulation of intracellular Ca(2+) mobilization has been associated with the functions of polycystin-1 (PC1) and polycystin-2 (PC2), the protein products of the PKD1 and PKD2 genes. We have now demonstrated that PC1 can activate the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway through Galpha(q) -mediated activation of phospholipase C (PLC). Transient transfection of HEK293T cells with an NFAT promoter-luciferase reporter demonstrated that membrane-targeted PC1 constructs containing the membrane proximal region of the C-terminal tail, which includes the heterotrimeric G protein binding and activation domain, can stimulate NFAT luciferase activity. Inhibition of glycogen synthase kinase-3beta by LiCl treatment further increased PC1-mediated NFAT activity. PC1-mediated activation of NFAT was completely inhibited by the calcineurin inhibitor, cyclosporin A. Cotransfection of a construct expressing the Galpha(q) subunit augmented PC1-mediated NFAT activity, whereas the inhibitors of PLC (U73122) and the inositol trisphosphate and ryanodine receptors (xestospongin and 2-aminophenylborate) and a nonspecific Ca(2+) channel blocker (gadolinium) diminished PC1-mediated NFAT activity. PC2 was not able to activate NFAT. An NFAT-green fluorescent protein nuclear localization assay demonstrated that PC1 constructs containing the C-tail only or the entire 11-transmembrane spanning region plus C-tail induced NFAT-green fluorescent protein nuclear translocation. NFAT expression was demonstrated in the M-1 mouse cortical collecting duct cell line and in embryonic and adult mouse kidneys by reverse transcriptase-PCR and immunolocalization. These data suggest a model in which PC1 signaling leads to a sustained elevation of intracellular Ca(2+) mediated by PC1 activation of Galpha(q) followed by PLC activation, release of Ca(2+) from intracellular stores, and activation of store-operated Ca(2+) entry, thus activating calcineurin and NFAT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466861     DOI: 10.1074/jbc.M402905200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Authors:  Nancy M Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

Review 2.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 3.  Fish and frogs: models for vertebrate cilia signaling.

Authors:  Oliver Wessely; Tomoko Obara
Journal:  Front Biosci       Date:  2008-01-01

4.  Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.

Authors:  David Merrick; Kavita Mistry; Jingshing Wu; Nikolay Gresko; Julie E Baggs; John B Hogenesch; Zhaoxia Sun; Michael J Caplan
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

Review 5.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

6.  Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathway.

Authors:  Netty G Santoso; Liudmila Cebotaru; William B Guggino
Journal:  Cell Physiol Biochem       Date:  2011-06-17

Review 7.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

8.  Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.

Authors:  Diederik van Bodegom; Wijnand Roessingh; Andrew Pridjian; Samir S El Dahr
Journal:  Biochim Biophys Acta       Date:  2010-04-11

Review 9.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

10.  Emerging evidence of a link between the polycystins and the mTOR pathways.

Authors:  Alessandra Boletta
Journal:  Pathogenetics       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.